Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current 0JAV market cap is 4.71B. The company's latest EPS is USD -5.1076 and P/E is -15.21.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 164.41M | 188.46M | 266.16M | 305.21M | 363.71M |
| Operating Income | -265.23M | -375.09M | -457.32M | -709.63M | -878.25M |
| Net Income | -294.09M | -434.65M | -481.53M | -749.57M | -913.77M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 796.16M | 1.24B | 1.66B | 1.33B | 2.03B |
| Total Liabilities | 520.27M | 833.04M | 1.57B | 1.66B | 1.74B |
| Total Equity | 275.88M | 410.47M | 87.95M | -331.92M | 285.38M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -219.35M | -363.3M | -400.44M | -536.25M | -683.88M |
| Investing | -6.82M | -64.29M | -34.58M | -223.6M | -583.18M |
| Financing | 271M | 612.55M | 793.27M | 168.44M | 1.34B |
| Market Cap | 4.71B |
| Price to Earnings Ratio | -15.21 |
| Price to Sales Ratio | 38.21 |
| Price to Cash Ratio | 25.04 |
| Price to Book Ratio | 48.7 |
| Dividend Yield | - |
| Shares Outstanding | 178.9M |
| Average Volume (1 week) | 41 |
| Average Volume (1 Month) | 278 |
| 52 Week Change | 0.00% |
| 52 Week High | 26.33 |
| 52 Week Low | 26.33 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Insmed Inc |
| Address |
10 finderne avenue bridgewater, new jersey 08807 |
| Website | https://www.insmed.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
